Literature DB >> 23946627

Nuedexta for the treatment of pseudobulbar affect: a condition of involuntary crying or laughing.

Martin Paspe Cruz.   

Abstract

Dextromethorphan/quinidine (nuedexta) for pseudobulbar affect.

Entities:  

Year:  2013        PMID: 23946627      PMCID: PMC3737988     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  12 in total

1.  Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.

Authors:  Hillel S Panitch; Ronald A Thisted; Richard A Smith; Daniel R Wynn; James P Wymer; Anat Achiron; Timothy L Vollmer; Raul N Mandler; Dennis W Dietrich; Malcolm Fletcher; Laura E Pope; James E Berg; Ariel Miller
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

Review 2.  Review of pseudobulbar affect including a novel and potential therapy.

Authors:  Randolph Schiffer; Laura E Pope
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

3.  Defining and diagnosing involuntary emotional expression disorder.

Authors:  Jeffrey L Cummings; David B Arciniegas; Benjamin R Brooks; Robert M Herndon; Edward C Lauterbach; Erik P Pioro; Robert G Robinson; Douglas W Scharre; Randolph B Schiffer; Daniel Weintraub
Journal:  CNS Spectr       Date:  2006-06       Impact factor: 3.790

Review 4.  The differential diagnosis of pseudobulbar affect (PBA). Distinguishing PBA among disorders of mood and affect. Proceedings of a roundtable meeting.

Authors:  David B Arciniegas; Edward C Lauterbach; Karen E Anderson; Tiffany W Chow; Laura A Flashman; Robin A Hurley; Daniel I Kaufer; Thomas W McAllister; Alison Reeve; Randolph B Schiffer; Jonathan M Silver
Journal:  CNS Spectr       Date:  2005-05       Impact factor: 3.790

Review 5.  Pathological laughing and crying.

Authors:  F L Dark; J J McGrath; M A Ron
Journal:  Aust N Z J Psychiatry       Date:  1996-08       Impact factor: 5.744

Review 6.  The neuropsychiatry of pathologic affect: an approach to evaluation and treatment.

Authors:  D B Arciniegas; J Topkoff
Journal:  Semin Clin Neuropsychiatry       Date:  2000-10

7.  Pathological laughter and crying: a link to the cerebellum.

Authors:  J Parvizi; S W Anderson; C O Martin; H Damasio; A R Damasio
Journal:  Brain       Date:  2001-09       Impact factor: 13.501

8.  Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect.

Authors:  Erik P Pioro; Benjamin Rix Brooks; Jeffrey Cummings; Randolph Schiffer; Ronald A Thisted; Daniel Wynn; Adrian Hepner; Randall Kaye
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

9.  Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.

Authors:  B R Brooks; R A Thisted; S H Appel; W G Bradley; R K Olney; J E Berg; L E Pope; R A Smith
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

Review 10.  Diagnosis and management of pathological laughter and crying.

Authors:  Josef Parvizi; David B Arciniegas; Gary L Bernardini; Michael W Hoffmann; Jay P Mohr; Mark J Rapoport; Jeremy D Schmahmann; Jonathan M Silver; Stanley Tuhrim
Journal:  Mayo Clin Proc       Date:  2006-11       Impact factor: 7.616

View more
  6 in total

Review 1.  Dextromethorphan/quinidine: a review of its use in adults with pseudobulbar affect.

Authors:  Lily P H Yang; Emma D Deeks
Journal:  Drugs       Date:  2015-01       Impact factor: 9.546

Review 2.  Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.

Authors:  Kasper B Hansen; Lonnie P Wollmuth; Derek Bowie; Hiro Furukawa; Frank S Menniti; Alexander I Sobolevsky; Geoffrey T Swanson; Sharon A Swanger; Ingo H Greger; Terunaga Nakagawa; Chris J McBain; Vasanthi Jayaraman; Chian-Ming Low; Mark L Dell'Acqua; Jeffrey S Diamond; Chad R Camp; Riley E Perszyk; Hongjie Yuan; Stephen F Traynelis
Journal:  Pharmacol Rev       Date:  2021-10       Impact factor: 18.923

3.  Pharmacotherapy for the Pseudobulbar Affect in Individuals Who Have Sustained a Traumatic Brain Injury: a Systematic Review.

Authors:  Amelia J Hicks; Fiona J Clay; Jennie L Ponsford; Luke A Perry; Mahesh Jayaram; Rachel Batty; Malcolm Hopwood
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

Review 4.  Senolytics: A Novel Strategy for Neuroprotection in ALS?

Authors:  Alexandra Maximova; Eryn L Werry; Michael Kassiou
Journal:  Int J Mol Sci       Date:  2021-11-08       Impact factor: 5.923

5.  Pseudobulbar Affect Mimicking Depression: A Case Report.

Authors:  Victor Kekere; Danish Qureshi; Amod Thanju; Patrice Fouron; Tolulope Olupona
Journal:  Cureus       Date:  2022-06-23

6.  Treatment of pseudobulbar affect in a mixed neurodegenerative disorder with compounded quinidine capsules and dextromethorphan cough syrup.

Authors:  Yannick Villeneuve; Diana Cruz-Santiago; Helene Masson; Doris Clerc
Journal:  SAGE Open Med Case Rep       Date:  2020-06-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.